Vapotherm (VAPO) Misses Q4 EPS by 12c, Revenues Beat; Offers FY19 Revenue Mid-Point Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Vapotherm Reports Fourth Quarter and Fiscal Year 2018 Financial Results
March 12, 2019 4:13 PM EDT2018 Revenue of $42.4 Million Reflects 19.0% Increase Over Prior Year
EXETER, N.H.--(BUSINESS WIRE)-- Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory distress, announced today fourth quarter and fiscal year 2018 financial results.
Fourth Quarter 2018 Summary
Revenue for the fourth quarter of 2018 was $11.7 million, representing a 12.3% increase over the prior year period Gross margin was 41.2% in comparison to gross... More